445 related articles for article (PubMed ID: 23620106)
1. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
[TBL] [Abstract][Full Text] [Related]
2. The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy.
Roeleveld DM; Koenders MI
Cytokine; 2015 Jul; 74(1):101-7. PubMed ID: 25466295
[TBL] [Abstract][Full Text] [Related]
3. Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis.
Kugyelka R; Kohl Z; Olasz K; Mikecz K; Rauch TA; Glant TT; Boldizsar F
Mediators Inflamm; 2016; 2016():6145810. PubMed ID: 26903711
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis.
Benedetti G; Miossec P
Eur J Immunol; 2014 Feb; 44(2):339-47. PubMed ID: 24310226
[TBL] [Abstract][Full Text] [Related]
5. Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics.
van den Berg WB; McInnes IB
Semin Arthritis Rheum; 2013 Oct; 43(2):158-70. PubMed ID: 24157091
[TBL] [Abstract][Full Text] [Related]
6. IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation.
Ye L; Jiang B; Deng J; Du J; Xiong W; Guan Y; Wen Z; Huang K; Huang Z
J Immunol; 2015 Jun; 194(11):5110-9. PubMed ID: 25917106
[TBL] [Abstract][Full Text] [Related]
7. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
Yamagata T; Skepner J; Yang J
Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
[TBL] [Abstract][Full Text] [Related]
8. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
Zhu S; Qian Y
Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
[TBL] [Abstract][Full Text] [Related]
9. Targeting Th17 cells in autoimmune diseases.
Yang J; Sundrud MS; Skepner J; Yamagata T
Trends Pharmacol Sci; 2014 Oct; 35(10):493-500. PubMed ID: 25131183
[TBL] [Abstract][Full Text] [Related]
10. The IL-17 pathway as a major therapeutic target in autoimmune diseases.
Hu Y; Shen F; Crellin NK; Ouyang W
Ann N Y Acad Sci; 2011 Jan; 1217():60-76. PubMed ID: 21155836
[TBL] [Abstract][Full Text] [Related]
11. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.
Toussirot E
Inflamm Allergy Drug Targets; 2012 Apr; 11(2):159-68. PubMed ID: 22280236
[TBL] [Abstract][Full Text] [Related]
12. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.
Azizi G; Jadidi-Niaragh F; Mirshafiey A
Int J Rheum Dis; 2013 Jun; 16(3):243-53. PubMed ID: 23981743
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis.
van Hamburg JP; Tas SW
J Autoimmun; 2018 Feb; 87():69-81. PubMed ID: 29254845
[TBL] [Abstract][Full Text] [Related]
14. IL-17/Th17 mediated synovial inflammation is IL-22 independent.
van Hamburg JP; Corneth OB; Paulissen SM; Davelaar N; Asmawidjaja PS; Mus AM; Lubberts E
Ann Rheum Dis; 2013 Oct; 72(10):1700-7. PubMed ID: 23328939
[TBL] [Abstract][Full Text] [Related]
15. The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.
Schinnerling K; Aguillón JC; Catalán D; Soto L
Clin Exp Immunol; 2017 Jul; 189(1):12-20. PubMed ID: 28369786
[TBL] [Abstract][Full Text] [Related]
16. The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis.
Paulissen SM; van Hamburg JP; Dankers W; Lubberts E
Cytokine; 2015 Jul; 74(1):43-53. PubMed ID: 25828206
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune inflammation from the Th17 perspective.
Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR
Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553
[TBL] [Abstract][Full Text] [Related]
18. The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases.
Kuwabara T; Ishikawa F; Kondo M; Kakiuchi T
Mediators Inflamm; 2017; 2017():3908061. PubMed ID: 28316374
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting RORγt/Th17 axis for autoimmune disorders.
Isono F; Fujita-Sato S; Ito S
Drug Discov Today; 2014 Aug; 19(8):1205-11. PubMed ID: 24792721
[TBL] [Abstract][Full Text] [Related]
20. Role of IL-17 and IL-22 in autoimmunity and cancer.
Blake SJ; Teng MW
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]